Search Results Heading

MBRLSearchResults

mbrl.module.common.modules.added.book.to.shelf
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
    Done
    Filters
    Reset
  • Discipline
      Discipline
      Clear All
      Discipline
  • Is Peer Reviewed
      Is Peer Reviewed
      Clear All
      Is Peer Reviewed
  • Item Type
      Item Type
      Clear All
      Item Type
  • Subject
      Subject
      Clear All
      Subject
  • Year
      Year
      Clear All
      From:
      -
      To:
  • More Filters
2 result(s) for "Wolfert, Andreas"
Sort by:
Experimental colitis drives enteric alpha-synuclein accumulation and Parkinson-like brain pathology
Intraneuronal α-synuclein accumulation is key in Parkinson's disease (PD) pathogenesis. The pathogenic process is suggested to begin in the enteric nervous system and propagate into the brain already decades before diagnosis of PD. In some patients, colitis might play a critical role in this process. Here we demonstrate that patients with inflammatory bowel disease exhibit α-synuclein accumulation in the colon and that experimental colitis triggers α-synuclein accumulation in certain enteric nerves of mice. The type and degree of experimental inflammation modulates the extent of colonic α-synuclein accumulation and macrophage-related signaling limits this process. Remarkably, experimental colitis at three months of age exacerbates the accumulation of aggregated phospho-Serine 129 α-synuclein in the midbrain (including the substantia nigra), in 21- but not 9-month-old α-synuclein transgenic mice. This is accompanied by loss of tyrosine hydroxylase-immunoreactive nigral neurons. Our data suggest that intestinal inflammation might play a critical role in the initiation and progression of PD. Footnotes * Edited and updated entire manuscript (text, new references, figures) for submission to another journal. Content remains the same.
Results of an European survey on the management of perimesencephalic nonaneurysmal subarachnoid hemorrhage
Based on the current guidelines, there is no consensus on inpatient treatment including cerebral vasospasm prophylaxis and follow-up imaging for perimesencephalic nonaneurysmal subarachnoid hemorrhage (NASAH). To evaluate the daily practice of neurosurgeons within the Vascular Section of the European Association of Neurosurgical Societies (EANS) an online survey was performed from February 2023 to June 2023. Thirty-two questionnaires were answered from eighteen different countries. Most answers were provided from employees of University Hospitals ( n  = 27; 84.4%). Up to five NASAH cases per year were reported by 10 (31.3%), another 12 (37.4%) treat more than 20 cases. The majority of contributors (65.6%) estimate the complication rates in NASAH to be less than 2%. Inpatient monitoring was significantly influenced by the initial presentation and the distribution of blood observed in the CT scan, with significantly more patients being admitted to the intensive care unit in case 3 ( p  = 0.011) compared to case 1. Further, the therapeutic approaches differ in the blood pressure monitoring ( p  = 0.08). However, this finding did not achieve statistical significance. In case 1 and case 2 neither cerebral vasospasm prophylaxis nor transcranial doppler sonography is performed in 11 centers (34.4%) which decreases statistically significantly in case 3 ( n  = 2; 6.3%; p  = 0.0014). This study confirms that, the amount of blood in the first native CT scan influences the treatment decision. However, clear intercontinental differences cannot be evaluated due to the small number of participants.